According to the current analysis of Reports and Data, the global Digital Breast Tomosynthesis Market was valued at USD 1,945.8 Million in 2020 and is expected to reach USD 4,435.3 Million by the year 2028, at a CAGR of 11.4%. Digital Breast Tomosynthesis is an advanced type of imaging or x-ray technique that is majorly used in the detection of early signs and symptoms of breast cancer in women. Digital Breast Tomosynthesis, also termed as 3D mammography, is an advanced mammography technique that gives 3D images of breast of the patient. Digital Breast Tomosynthesis provides a much better version of breast images as it can be used for dense breast tissue and can detect even a small lesion of the breast. The early detection of breast cancer incidences and elimination of patient discomfort due to breast compression makes the Digital Breast Tomosynthesis technique efficient and widely accepted than the traditional mammography.

The market for Digital Breast Tomosynthesis or 3D mammography has been driven by the rising susceptibility of women to breast cancer across all socioeconomic classes, as well as campaigns and screenings for women's health. The market has been stimulated by the broad and intensive research environment, which has aided in the development of more precise and least invasive technologies for the early diagnosis of breast cancer. Government efforts to create an ongoing, all-encompassing environment for cancer research have also fuelled the development of this diagnostic tool. Also, advantageous reimbursements in this area have significantly strengthened the industry. The exorbitant price of the Digital Breast Tomosynthesis device, however, is anticipated to impede commercial expansion.

Request Free Sample Copy @ https://www.reportsanddata.com/download-free-sample/2373

Further key findings from the report suggest

• Various government organization and research institutes are engaged in clinical trials of the Digital Breast Tomosynthesis to evaluate the efficiency of the device in case of early diagnosis of breast cancer. For instance, Cancer Prevention and Research Institute, Italy is engaged in study of the Innovation in Mammography: Digital Breast Tomosynthesis Pathways (IMPETO)
• Favorable reimbursement policy such as, Medicare and other private insurer reimburse the women undergoing digital breast Digital Breast Tomosynthesis is expected to fuel the market growth of the Digital Breast Tomosynthesis in breast imaging application area
• Various industry players are focusing on expanding the product portfolio in the field. For instance, FUJIFILM Medical Systems U.S.A., Inc., one of the leading provider of diagnostic imaging and medical informatics solutions, in July 2019 launched its Digital Breast Tomosynthesis Biopsy option for the ASPIRE Cristalle mammography system
• Various key players are focused in developing the advanced technologies in Digital Breast Tomosynthesis. For instance, Siemens Healthineers received FDA approval for its latest mammography machine, the Mammomat Revelation a mammography platform with the new InSpect integrated specimen imaging tool and the new HD Breast Biopsy solution for one-click targeting of suspicious areas
• During 2019-2026, Digital Breast Tomosynthesis market is expected to register a CAGR of 12.0% in Asia Pacific; followed by North America and Europe, with 11.7% and 11.3% CAGR, respectively. High prevalence of breast cancer and related diseases across the globe is the major factor driving the market during the forecast period across all regions.
• The standalone 3D system product type of Digital Breast Tomosynthesis segment dominates the field with highest market share in the year 2018. It is estimated to grow at a CAGR of 11.8% during the forecast period to reach USD 2.9 billion by 2026
• Based on application segment, breast cancer is expected to account for the CAGR 11.8% of the global Digital Breast Tomosynthesis market, as drastically growing incidences of breast cancer across the world and raising public awareness about the diagnostic and preventive measures for the breast cancer
• Asia Pacific is expected to account for the CAGR 12.0% of the global Digital Breast Tomosynthesis market. Developing nations such China, and India are likely to witness high growth due to high prevalence of diseases, increased healthcare expenditure and growing RD investment
• Based on end use hospitals dominate the total market share of Digital Breast Tomosynthesis. As the availability of skilled personnel and quality equipment facilities at hospital
• High cost of the tomoynthesis or 3D mammography device is the key factors likely to hamper growth of the Digital Breast Tomosynthesis market

Key Players covered in this report are

Hologic Inc., Siemens Healthineers, Fujifilm Corporation, GE Healthcare, Planmeca, iCAD and Dexela Ltd. 

Product Outlook (Revenue, USD Million; 2018-2028)

• 2D and 3D combination System
• Standalone 3D system

Component Outlook (Revenue, USD Million; 2018-2028)

• Display system
• Face Shield
• Paddle System
• Tube Head

Application Outlook (Revenue, USD Million; 2018-2028)

• Breast Cancer Screening
• Chest Imaging
  • Detection of Pulmonary Nodules
  • Evaluation of Interstitial Lung Disease
  • Detection of Subtle Pneumothoraces
  • Evaluation of Fractures
    • Rib
    • Spine
    • Clavicle
  • Detection of Coronary Artery and Aortic Calcification
  • Visualization and Scoring of Cystic Fibrosis
  • Others
• Evaluation of Erosions in Rheumatoid Arthritis
• Head and Neck Imaging
• Others

End Use Outlook (Revenue, USD Million; 2018-2028)

• Hospital
• Diagnostic Centers
• Others

Geographic Segment Covered in the Report:

The Digital Breast Tomosynthesis report provides information about the market area, which is further subdivided into sub-regions and countries/regions. In addition to the market share in each country and sub-region, this chapter of this report also contains information on profit opportunities. This chapter of the report mentions the market share and growth rate of each region, country, and sub-region during the estimated period.

• North America (USA and Canada)
• Europe (UK, Germany, France and the rest of Europe)
• Asia Pacific (China, Japan, India, and the rest of the Asia Pacific region)
• Latin America (Brazil, Mexico, and the rest of Latin America)
• Middle East and Africa (GCC and rest of the Middle East and Africa)

Major Points covered in this report are as below:

• The Digital Breast Tomosynthesis industry development trends and marketing channels are analyzed. The feasibility of new investment projects are assessed and overall research conclusions offered.

• With the tables and figures, the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

• Development policies and plans, manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand figures, cost, price, revenue and gross margins.

• The Digital Breast Tomosynthesis Market report provides key statistics on the market status of the Digital Breast Tomosynthesis manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.

We can also provide the customized data for separate regions like North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of Europe, Central South America, Brazil, Argentina, Rest of South America, Middle East Africa, Saudi Arabia, Turkey, Rest of Middle East Africa

Request customization of the report @ https://www.reportsanddata.com/request-customization-form/2373

Thank you for reading our research report. Kindly contact us to know more about the customization feature and plans and out team will help you with the best suited report as per your requirement.

Get Explore Latest Research Report by Reports and Data:

Surgical Needle Market @ https://www.reportsanddata.com/report-detail/surgical-needle-market

Virtual Clinical Trial Market @ https://www.reportsanddata.com/report-detail/virtual-clinical-trial-market

Topical Corticosteroids Market @ https://www.reportsanddata.com/report-detail/topical-corticosteroids-market

Spinal Traction Market @ https://www.reportsanddata.com/report-detail/spinal-traction-market

http://image.google.cat/url?q=https://www.reportsanddata.com/

http://image.google.co.bw/url?q=https://www.reportsanddata.com/

https://image.google.co.zm/url?q=https://www.reportsanddata.com/

http://image.google.as/url?q=https://www.reportsanddata.com/

https://images.google.rs/url?q=https://www.reportsanddata.com/

http://image.google.ba/url?q=https://www.reportsanddata.com/

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, TouchPoints, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provide our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: [email protected]